Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus

Por Lopez, Janice M.S., Macomson, Brian, Ektare, Varun, Patel, Dipen, Botteman, Marc
Publicado no Am Health Drug Benefits (2015)

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patie...

Por Aletaha, Daniel, Snedecor, Sonya J, Ektare, Varun, Xue, Mei, Bao, Yanjun, Garg, Vishvas
Publicado no Clinicoecon Outcomes Res (2017)